Morgan Stanley’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $170K | Sell |
11,350
-797
| -7% | -$11.7K | ﹤0.01% | 5942 |
|
|
2025
Q4 | $162K | Sell |
12,147
-3,030
| -20% | -$44.3K | ﹤0.01% | 6008 |
|
|
2025
Q3 | $239K | Sell |
15,177
-2,412
| -14% | -$39.7K | ﹤0.01% | 5819 |
|
|
2025
Q2 | $265K | Sell |
17,589
-2,607
| -13% | -$38.1K | ﹤0.01% | 5738 |
|
|
2025
Q1 | $304K | Sell |
20,196
-6,315
| -24% | -$93.4K | ﹤0.01% | 5553 |
|
|
2024
Q4 | $382K | Sell |
26,511
-70,280
| -73% | -$1.26M | ﹤0.01% | 5534 |
|
|
2024
Q3 | $1.89M | Buy |
96,791
+12,954
| +15% | +$234K | ﹤0.01% | 4691 |
|
|
2024
Q2 | $1.44M | Buy |
83,837
+50,521
| +152% | +$932K | ﹤0.01% | 4769 |
|
|
2024
Q1 | $560K | Sell |
33,316
-42,408
| -56% | -$643K | ﹤0.01% | 5264 |
|
|
2023
Q4 | $1.37M | Buy |
75,724
+29,546
| +64% | +$537K | ﹤0.01% | 5149 |
|
|
2023
Q3 | $782K | Buy |
46,178
+2,752
| +6% | +$39.4K | ﹤0.01% | 4937 |
|
|
2023
Q2 | $521K | Sell |
43,426
-29,380
| -40% | -$401K | ﹤0.01% | 5190 |
|
|
2023
Q1 | $948K | Sell |
72,806
-73,187
| -50% | -$1.2M | ﹤0.01% | 4893 |
|
|
2022
Q4 | $2.16M | Sell |
145,993
-99,607
| -41% | -$1.09M | ﹤0.01% | 4415 |
|
|
2022
Q3 | $2.17M | Buy |
245,600
+11,568
| +5% | +$146K | ﹤0.01% | 4369 |
|
|
2022
Q2 | $2.96M | Buy |
234,032
+46,997
| +25% | +$598K | ﹤0.01% | 4226 |
|
|
2022
Q1 | $3.54M | Buy |
187,035
+7,091
| +4% | +$181K | ﹤0.01% | 4042 |
|
|
2021
Q4 | $6.31M | Sell |
179,944
-76,680
| -30% | -$2.49M | ﹤0.01% | 3467 |
|
|
2021
Q3 | $9.39M | Buy |
256,624
+56,445
| +28% | +$2.22M | ﹤0.01% | 2965 |
|
|
2021
Q2 | $7.86M | Sell |
200,179
-21,888
| -10% | -$632K | ﹤0.01% | 3274 |
|
|
2021
Q1 | $6.27M | Sell |
222,067
-47,949
| -18% | -$1.53M | ﹤0.01% | 3173 |
|
|
2020
Q4 | $8.65M | Buy |
270,016
+183,672
| +213% | +$5.65M | ﹤0.01% | 2668 |
|
|
2020
Q3 | $2.79M | Buy |
86,344
+30,827
| +56% | +$961K | ﹤0.01% | 3339 |
|
|
2020
Q2 | $1.53M | Sell |
55,517
-50,257
| -48% | -$1.09M | ﹤0.01% | 3835 |
|
|
2020
Q1 | $1.89M | Sell |
105,774
-23,967
| -18% | -$578K | ﹤0.01% | 3417 |
|
|
2019
Q4 | $3.25M | Buy |
129,741
+102,597
| +378% | +$2.25M | ﹤0.01% | 3639 |
|
|
2019
Q3 | $484K | Buy |
27,144
+3,156
| +13% | +$65.7K | ﹤0.01% | 4694 |
|
|
2019
Q2 | $528K | Sell |
23,988
-17,504
| -42% | -$500K | ﹤0.01% | 4583 |
|
|
2019
Q1 | $1.27M | Sell |
41,492
-10,607
| -20% | -$265K | ﹤0.01% | 3951 |
|
|
2018
Q4 | $1.2M | Buy |
52,099
+48,873
| +1,515% | +$1.52M | ﹤0.01% | 4145 |
|
|
2018
Q3 | $104K | Sell |
3,226
-14,623
| -82% | -$446K | ﹤0.01% | 5670 |
|
|
2018
Q2 | $538K | Buy |
17,849
+6,520
| +58% | +$207K | ﹤0.01% | 5050 |
|
|
2018
Q1 | $334K | Buy |
11,329
+11,197
| +8,483% | +$398K | ﹤0.01% | 5225 |
|
|
2017
Q4 | $5K | Sell |
132
-6,165
| -98% | -$197K | ﹤0.01% | 6334 |
|
|
2017
Q3 | $171K | Sell |
6,297
-668
| -10% | -$16.4K | ﹤0.01% | 5416 |
|
|
2017
Q2 | $163K | Buy |
6,965
+6,818
| +4,638% | +$140K | ﹤0.01% | 5440 |
|
|
2017
Q1 | $3K | Buy |
+147
| New | +$2.21K | ﹤0.01% | 6419 |
|
|
2016
Q4 | – | Sell |
-35,349
| Closed | -$421K | – | 6537 |
|
|
2016
Q3 | $421K | Buy |
+35,349
| New | +$452K | ﹤0.01% | 4625 |
|
|
2016
Q2 | – | Sell |
-11
| Closed | – | – | 6563 |
|
|
2016
Q1 | $0 | Buy |
+11
| New | +$147 | ﹤0.01% | 6632 |
|
Other funds holding HCM
AG
MGP
CGH
Morgan Stanley's HCM Position: Q1 2026 in Review
Morgan Stanley reduced its HUTCHMED (HCM) stake by 6.6% in Q1 2026, selling an estimated $11.7K and leaving 11,350 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #5942.
Morgan Stanley first reported a position in HCM in Q1 2016 and has held it in 39 quarters since. The position peaked at $9.39M in Q3 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.
- Morgan Stanley held 11,350 shares of HUTCHMED worth $170K as of Q1 2026.
- Morgan Stanley sold 797 HUTCHMED shares in Q1 2026, an estimated $11.7K.
- HUTCHMED made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5942 holding.
- Morgan Stanley first reported a position in HUTCHMED in Q1 2016 and has held it in 39 quarters since.
- Morgan Stanley's HUTCHMED position peaked at $9.39M in Q3 2021.
- 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.